Resistance to Androgen-Pathway Drugs in Prostate Cancer: Reply

Emmanuel S. Antonarakis; Mary Nakazawa; Jun Luo

doi:10.1056/NEJMc1412594

Resistance to Androgen-Pathway Drugs in Prostate Cancer: Reply

Emmanuel S. Antonarakis, Mary Nakazawa, Jun Luo

School of Medicine

Research output: Contribution to journal › Letter › peer-review

20 Scopus citations

Original language	English (US)
Number of pages	1
Journal	New England Journal of Medicine
Volume	371
Issue number	23
DOIs	https://doi.org/10.1056/NEJMc1412594
State	Published - Dec 4 2014

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMc1412594

Cite this

@article{04a9f999238149d297313bfd4f646eeb,

title = "Resistance to Androgen-Pathway Drugs in Prostate Cancer: Reply",

author = "Antonarakis, {Emmanuel S.} and Mary Nakazawa and Jun Luo",

year = "2014",

month = dec,

day = "4",

doi = "10.1056/NEJMc1412594",

language = "English (US)",

volume = "371",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "23",

}

TY - JOUR

T1 - Resistance to Androgen-Pathway Drugs in Prostate Cancer

T2 - Reply

AU - Antonarakis, Emmanuel S.

AU - Nakazawa, Mary

AU - Luo, Jun

PY - 2014/12/4

Y1 - 2014/12/4

UR - http://www.scopus.com/inward/record.url?scp=84918791556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918791556&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1412594

DO - 10.1056/NEJMc1412594

M3 - Letter

C2 - 25470700

AN - SCOPUS:84918791556

SN - 0028-4793

VL - 371

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 23

ER -

Resistance to Androgen-Pathway Drugs in Prostate Cancer: Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this